# Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation

> **NCT02664389** · NA · TERMINATED · sponsor: **University Hospital, Rouen** · enrollment: 289 (actual)

## Conditions studied

- Breast Cancer
- Ovarian Cancer
- Colorectal Cancer
- Pediatric Cancers
- Multiple Primary Malignant Tumours

## Interventions

- **GENETIC:** Genetic analysis

## Key facts

- **NCT ID:** NCT02664389
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02-01
- **Primary completion:** 2017-03-15
- **Final completion:** 2017-03-15
- **Target enrollment:** 289 (ACTUAL)
- **Why stopped:** Difficulty in enrolling patients
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02664389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02664389, "Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02664389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*